Ureteral Endometriosis Presenting as Recurrent Hydronephrosis: A Case Report [0.03%]
输尿管子宫内膜异位症致反复肾积水：一例报告
Omar Al Ayoubi,Mohammad Alaa Aldakak,Grace Tannous et al.
Omar Al Ayoubi et al.
Ureteral endometriosis is an uncommon but potentially serious manifestation of deep endometriosis that may remain undetected until significant renal damage has occurred. We report the case of a 35-year-old woman with a 4-year history of rig...
Management and Treatment of Benign Prostatic Hyperplasia Symptoms: Current Insights [0.03%]
良性前列腺增生症状的管理和治疗：当前观点
Othmane Zekraoui,Naeem Bhojani,Kevin C Zorn et al.
Othmane Zekraoui et al.
Benign prostatic hyperplasia (BPH) is a common cause of lower urinary tract symptoms (LUTS) in aging men that can significantly impair their quality of life. This review provides updated insights into this condition's pathophysiology, diagn...
Prostate Cancer Among Patients Presenting with Obstructive Lower Urinary Tract Symptoms at a Tertiary Hospital in South Western Uganda [0.03%]
乌干达西南部一家三级医院因下尿路梗阻症状就诊的前列腺癌患者
Willy Kyegombe,Okidi Ronald,Anitah Nimusima et al.
Willy Kyegombe et al.
Background: Prostate cancer is currently the second commonest male cancer both globally and in Uganda. Men are often tested after presenting with obstructive lower urinary tract symptoms (LUTS). We evaluated total prostat...
Influencing Factors and Risk Prediction Model Construction of Urinary Tract Infections in Patients with Bladder Cancer [0.03%]
膀胱癌患者泌尿系统感染的影响因素及风险预测模型构建
Yancheng Di,Lingling Zhang,Linlin Zhao et al.
Yancheng Di et al.
Purpose: Urinary tract infections (UTI) are a common complication in patients with bladder cancer (BLCA). This study investigated the role of stearoyl-CoA desaturase-1 (SCD1) in BLCA progression and assessed its potential...
Preoperative β2 Microglobulin Is a Prognostic Factor in Patients with Renal Cell Carcinoma and Normal Kidney Function [0.03%]
术前β2微球蛋白是肾癌且肾功能正常的患者的预后因素
Gregory Palmateer,Eduoard H Nicaise,Taylor Goodstein et al.
Gregory Palmateer et al.
Introduction: β2 microglobulin is a non-glycosylated protein synthesized by all nucleated cells. It has been utilized as a tumor marker in several different malignancies, however, studies examining its role in renal cell...
Clinical Outcomes of Avelumab Maintenance Following Full-Dose, Reduced-Dose Cisplatin, or Carboplatin-Based Chemotherapy in Advanced Urothelial Carcinoma [0.03%]
阿维单抗作为全剂量顺铂、减剂量顺铂或卡铂化疗后的维持治疗在晚期尿路上皮癌中的临床疗效分析
Nobuki Furubayashi,Jiro Tsujita,Azusa Takayama et al.
Nobuki Furubayashi et al.
Background: Avelumab maintenance therapy is a standard of care for patients with advanced urothelial carcinoma (UC) who achieve disease control following platinum-based chemotherapy. However, the influence of induction ch...
Radiation Therapy for Local or Biochemical Recurrence Following Radical Prostatectomy in Patients with Prostate Cancer [0.03%]
根治性前列腺切除术后局部或生化复发的放射治疗
Hiroki Nishiyama,Gen Kawaguchi,Kozue Ito et al.
Hiroki Nishiyama et al.
Introduction and objectives: To investigate outcomes of patients with biochemical or local recurrence, without distant metastasis, who received radiation therapy targeting the prostate bed at our hospital following radica...
Kazuhiro Fukuda,Satoru Kotoda,Kaori Fukaya et al.
Kazuhiro Fukuda et al.
Background: Non-epithelial bladder neoplasms are rare, and there are only approximately 250 cases of bladder leiomyoma reported in the English literature. We present a case of bladder leiomyoma in a patient with recurrent...
Ten-Year Trends in Digital Rectal Exam Results and Prostate Cancer Detection: Insights from the PLCO Trial [0.03%]
PLCO试验中十年来的直肠指检结果及前列腺癌检出率的变化趋势
Kevin Guan,Bassam Dahman,Shyh-Han Tan et al.
Kevin Guan et al.
Objective: Digital Rectal Examination (DRE) remains an important preventive measure in primary care settings, but a single screening may produce false positives. We sought to explore the trend of abnormal DRE (suspicious ...
The Use of Artificial Intelligence in Urologic Oncology: Current Insights and Challenges [0.03%]
泌尿生殖系统肿瘤学中人工智能的应用：当前见解与挑战
Rossella Cicchetti,Daniele Amparore,Flavia Tamborino et al.
Rossella Cicchetti et al.
Artificial intelligence (AI) is increasingly influencing the field of urologic oncology, offering novel tools to support for clinical decision-making, enhance diagnostic precision, and assist in surgical and pathological workflows. Machine ...